Aggarwal Gaurav bought UNCY
July 28, 2025 · Form 4 insider transaction
Aggarwal Gaurav bought 21,200 shares of Unicycive Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
21,200
Price
$0.00
Total value
N/A
InsiderAggarwal Gaurav
RoleDirector
SecurityStock Options
Transaction codeA: Grant or award
Transaction dateJuly 28, 2025
Filing dateJuly 30, 2025
Shares owned after39,200
OwnershipDirect
10b5-1 planNo
AmendedNo